SpyridonDefteraiosMD

PubMed

• Molecular docking cannot accurately predict drug off-target effects: implications for the role of voriconazole in the exacerbation of myasthenia gravis.
  Deftereos SN> ;Muscle Nerve. 2014 Jan
• From depression to neurodegeneration and heart failure: re-examining the potential of MAO inhibitors.
  Deftereos SN Dodou E Andronis C Persidis A> ;Expert Rev Clin Pharmacol. 2012 Jul
• Treatment of idiopathic intracranial hypertension: Is there a place for octreotide?
  Deftereos SN Panagopoulos G Georgonikou D Karageorgiou CE Karageorgiou E Piadites G> ;Cephalalgia. 2011 Dec
• Literature mining, ontologies and information visualization for drug repurposing.
  Andronis C Sharma A Virvilis V Deftereos S Persidis A> ;Brief Bioinform. 2011 Jul
• Drug repurposing and adverse event prediction using high-throughput literature analysis.
  Deftereos SN Andronis C Friedla EJ Persidis A Persidis A> ;Wiley Interdiscip Rev Syst Biol Med. 2011 May-Jun
• Discordant effects of rasagiline doses in Parkinson disease.
  Deftereos SN Andronis CA> ;Nat Rev Neurol. 2010 Jul
• Localisation of cervical spinal cord compression by TMS and MRI.
  Deftereos SN Kechagias EA Panagopoulos G Seretis A Orphanidis G Antoniou E Georgakoulias N Karageorgou CE> ;Funct Neurol. 2009 Apr-Jun
• Test-retest reliability of p13n23 and n34p44 components of vestibular evoked myogenic potentials in a large healthy population.
  Eleftheriadou A Deftereos S Zarikas V Panagopoulos G Sfetsos S Karageorgiou K Ferekidou E Korres S Kandiloros D> ;J Otolaryngol Head Neck Surg. 2009 Aug
• Diagnosis of nonorganic monoplegia with single-pulse transcranial magnetic stimulation.
  Deftereos SN Panagopoulos GN Georgonikou DD Karageorgiou EC Kefalou PN Karageorgiou CE> ;Prim Care Companion J Clin Psychiatry. 2008
• On the calculation of transcallosal conduction time using transcranial magnetic stimulation.
  Deftereos SN Panagopoulos G Georgonikou D Karageorgiou E Andriopoulos P Karageorgiou CE> ;Funct Neurol. 2008 Jul-Sep
• Vestibular evoked myogenic potential eliciting in normal subjects: comparison of four different methods.
  Eleftheriadou A Deftereos SN Zarikas V Panagopoulos G Korres S Sfetsos S Karageorgiou KL Ferekidou E Kandiloros D> ;J Otolaryngol Head Neck Surg. 2008 Oct
• Intensive chelation therapy in beta-thalassemia and possible adverse cardiac effects of desferrioxamine.
  Aessopos A Kati M Farmakis D Polonifi E Deftereos S Tsironi M> ;Int J Hematol. 2007 Oct
• Predictive echo-Doppler indices of left ventricular impairment in B-thalassemic patients.
  Aessopos A Deftereos S Tsironi M Karabatsos F Yousef J Fragodimitri C Hatziliami A Karagiorga M> ;Ann Hematol. 2007 Jun
• Hypoparathyroidism and heart failure in thalassemic patients: a case report.
  Tsironi M Korovesis K Farmakis D Deftereos S Aessopos A> ;Pediatr Endocrinol Rev. 2004 Dec
• Aortic valve replacement in a patient with thalassemia intermedia.
  Farmakis D Polonifi A Deftereos S Tsironi M Papaioannou I Aessopos A> ;Ann Thorac Surg. 2006 Feb
• Does heterozygous beta-thalassemia confer a protection against coronary artery disease?
  Tassiopoulos S Deftereos S Konstantopoulos K Farmakis D Tsironi M Kyriakidis M Aessopos A> ;Ann N Y Acad Sci. 2005
• Technical guidelines for enhancing privacy and data protection in modern electronic medical environments.
  Gritzalis S Lambrinoudakis C Lekkas D Deftereos S> ;IEEE Trans Inf Technol Biomed. 2005 Sep
• Identification of echocardiographic indices for the early detection of left-ventricular systolic dysfunction in beta-thalassaemia via Self-Organizing Maps: a data-expl...
  Deftereos S Georgonikou D Persidis A Andronis C Aessopos A> ;Med Inform Internet Med. 2005 Mar
• Myelodysplastic syndrome associated with multiple autoimmune disorders.
  Farmakis D Polymeropoulos E Polonifi A Deftereos S Giakoumi X Floudas H Grapsa A Aessopos A> ;Clin Rheumatol. 2005 Aug
• Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.
  Aessopos A Farmakis D Deftereos S Tsironi M Tassiopoulos S Moyssakis I Karagiorga M> ;Chest. 2005 May
• Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
  Aessopos A Farmakis D Deftereos S Tsironi M Polonifi A Moyssakis I Diamanti-Kandaraki E Papalambros E> ;Ann Hematol. 2005 Jun
• Cardiovascular adaptation to chronic anemia in the elderly: an echocardiographic study.
  Aessopos A Deftereos S Farmakis D Corovesis C Tassiopoulos S Tsironi M Georgonikou D Moyssakis J> ;Clin Invest Med. 2004 Oct
• Hemodynamic assessment of splenomegaly in beta-thalassemia patients undergoing splenectomy.
  Aessopos A Farmakis D Tsironi M Deftereos S Tassiopoulos S Konstantopoulos K Rombos J Papalambros E> ;Ann Hematol. 2004 Dec
• Systems literature analysis.
  Persidis A Deftereos S Persidis A> ;Pharmacogenomics. 2004 Oct
• The patient with rhabdomyolysis: have you considered quail poisoning?
  Tsironi M Andriopoulos P Xamodraka E Deftereos S Vassilopoulos A Asimakopoulos G Aessopos A> ;CMAJ. 2004 Aug 17
• Join now to see all